2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

(2016) Paul A. Heidenreich et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

(2014) Rick A. Nishimura et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention

(2012) Paul D. Ziegler et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation

(2012) Pamela K. Mason et al.   AMERICAN JOURNAL OF MEDICINE

Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

(2012) Deirdre A. Lane et al.   CIRCULATION

Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice

(2012) Chern-En Chiang et al.   Circulation-Arrhythmia and Electrophysiology

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation

(2012) Greg Flaker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

(2012) Christian Torp-Pedersen et al.   THROMBOSIS AND HAEMOSTASIS

Atrial fibrillation

(2011) Gregory YH Lip et al.   LANCET

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

ACCF/AHA New Insights Into the Methodology of Performance Measurement

(2010) John A. Spertus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Home Testing of International Normalized Ratio on Clinical Events

(2010) David B. Matchar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence of Newly Detected Atrial Arrhythmias via Implantable Devices in Patients With a History of Thromboembolic Events

(2010) Paul D. Ziegler et al.   STROKE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk

(2009) Taya V. Glotzer et al.   Circulation-Arrhythmia and Electrophysiology

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of stroke in patients with atrial fibrillation: current strategies and future directions

(2008) S. H. Hohnloser et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS